Wednesday,
December 5, 2007 |
Opening Statements
- Michael J. Astrue, Commissioner of Social Security
- Stephen Groft, Pharm. D., Director, NIH Office of Rare Diseases
- Frank Cristaudo, Chief Administrative Law Judge
- David Rust, Acting Deputy Commissioner for Disability and Income Security Programs
Rare Disease Panel One
- Kathy Hunter, Founder & President, International Rett Syndrome Association [testimony]
- Craig Polhemus, Executive Director, Prader-Willi Syndrome Association [testimony]
- Vicky Whittemore, Ph.D., Vice President & Science Director, Tuberous Sclerosis Alliance [testimony]
Rare Disease Panel Two
- Suzanne R. Pattee, J.D., Vice President of Regulatory & Patient Affairs, Cystic Fibrosis Foundation, with Dr. Michael P. Boyle, Director, Johns Hopkins Adult Cystic Fibrosis Program [testimony]
- Barbara T. Boyle, National Executive Director & CEO, Huntington's Disease Society of America with Andrew S. Feigin, M.D. [testimony]
- Pat Furlong, President, Parent Project Muscular Dystrophy [testimony]
Rare Disease Panel Three
- Shelley Bowen, President, Barth Syndrome Foundation [testimony]
- Josephine Grima, Ph.D., Vice President of Research & Legislative Affairs, National Marfan Foundation [testimony]
- Amy K. Kirk, MSW, Coordinator of Family Services, Batten Disease Support and Research Association [testimony]
Audience Comments
Closing Remarks |
Get Adobe Reader |